Our Speakers



Our Speakers

Lior Raviv
Lior Raviv

Bo Kara
Bo Kara

Head Process Development, Cell & Gene Therapy Platform CMC, GSK, United Kingdom

Giuliana Vallanti
Giuliana Vallanti

Development & Quality Control Director Molmed Italy

Jean-Charles Epinat
Jean-Charles Epinat

Chief Technological Officer, Cellectis, France

Jef Pinxteren
Jef Pinxteren

Director process development, Promethera, Belgium

Klaus Cichutek
Klaus Cichutek

President, Paul-Ehrlich-Institut, Germany

Lior Raviv
Lior Raviv

VP Development ,Pluristem Therapeutics, Israel

Lisa O'Flynn
Lisa O'Flynn

Head of Process Development, Orbsen Therapeutics, Ireland

Mannuel Carrando
Mannuel Carrando

Vice President, IBET, Portugal

Matthew Durdy
Matthew Durdy

Chief Business officer, CT Catapult, United Kingdom

Pierre Heimendinger
Pierre Heimendinger

Head of Pharmaceutical Development, TxCell, France

Robert Thomas
Robert Thomas

Professor of Manufacturing for Cell and Gene Therapies, Loughborough University, United Kingdom

Sarah Snykers
Sarah Snykers

QC Manager, Celyad, Belgium

Shimon Slavin
Shimon Slavin

Professor of Medicine, Biotherapy International, Israel

Stefano Baila
Stefano Baila

Holding F.I.S, Belgium

Vicki Coutinho
Vicki Coutinho

Director, Regulatory Affairs , Autolus Ltd., United Kingdom

Yuan Zhao
Yuan Zhao

Leader, Gene Therapy Section, NIBSC, United Kingdom